Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial
Author(s):
Vliek, S.; Jager, A.; Jonge-Lavrencic, M.; Lotz, J.P.; Goncalves, A.; Graeser, M.; Nitz, U.; Mandjes, I.A.M.; Holtkamp, M.J.; Schot, M.; Retel, V.P.; Kuip, E.J.; Wymenga, M.N.; Konings, I.R.; Tjan-Heijnen, V.C.G.; Kroep, J.R.; Schr, D.P.; Wall, E. van der; Linn, S.C.
